Duopharma Biotech Posts Creditable Q2 with PBT Climbing to RM19.39 Million
KUALA LUMPUR, 13 AUGUST 2020 – Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company”) has posted a creditable set of financial results for the second quarter ended 30 June 2020 with profit before tax climbing to RM19.39 million (2019: RM18.32 million) against revenue of RM143.33 million (2019: RM145.47 million).